BTK inhibitor

Pleasanton, California, September 1, 2026 Veeva Systems has announced Veeva Falcon Safety, an agentic safety operations product designed to...

Raleigh, North Carolina, and Tel Aviv, Israel, September 1, 2026 RedHill Biopharma Ltd. has announced a major expansion of...

Chicago, Illinois, September 1, 2026 Xentria, Inc., a clinical-stage biotherapeutics company, has announced its next-stage clinical development plan for...

Basel, Switzerland, September 1, 2026 Novartis has announced positive topline results from the Phase III REMODEL-1 and REMODEL-2 trials,...

BEIJING, Aug. 4, 2026 InnoCare Pharma announced that the China National Medical Products Administration (NMPA) Center for Drug Evaluation...

CAMBRIDGE, Mass., July 31, 2026 CREATE Medicines has announced a strategic research collaboration and exclusive worldwide licensing agreement with...

LEXINGTON, Mass., July 30, 2026 Curis, Inc. has reached an important clinical milestone by successfully dosing the first five...

LEXINGTON, Mass., July 6, 2026 Curis, Inc. announced an important enrollment milestone for its Phase 2 TakeAim CLL clinical...

PARIS, June 23, 2026 Sanofi has secured an important regulatory milestone after Japan’s Ministry of Health, Labour and Welfare...

SHANGHAI, China, June 26, 2026 Everest Medicines announced a significant regulatory milestone after China’s National Medical Products Administration (NMPA)...